IAP
LLY icon

Indie Asset Partners’s Eli Lilly LLY Stock Holding History

Indie Asset Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Buy
9,677
+403
+4% +$412K 11.12% 1
2026
Q1 		$8.53M Sell
9,274
-2,262
-20% -$2.29M 9.72% 1
2025
Q4 		$12.4M Buy
11,536
+2,322
+25% +$2.22M 13.82% 1
2025
Q3 		$7.03M Buy
9,214
+7,941
+624% +$5.91M 9.36% 1
2025
Q2 		$992K Sell
1,273
-57,944
-98% -$45M 1.81% 15
2025
Q1 		$48.9M Sell
59,217
-608
-1% -$506K 42.4% 1
2024
Q4 		$46.2M Sell
59,825
-880
-1% -$729K 36.27% 1
2024
Q3 		$53.8M Buy
60,705
+7
+0% +$6.29K 40.28% 1
2024
Q2 		$55M Sell
60,698
-4,282
-7% -$3.43M 43.76% 1
2024
Q1 		$50.6M Sell
64,980
-147
-0.2% -$105K 44.99% 1
2023
Q4 		$38M Buy
65,127
+77
+0.1% +$44.9K 34.25% 1
2023
Q3 		$34.9M Buy
65,050
+61
+0.1% +$31.4K 35.22% 1
2023
Q2 		$30.5M Sell
64,989
-400
-0.6% -$168K 33.15% 1
2023
Q1 		$22.5M Buy
65,389
+851
+1% +$287K 26.23% 1
2022
Q4 		$23.6M Sell
64,538
-2,216
-3% -$786K 25.88% 1
2022
Q3 		$21.6M Sell
66,754
-90
-0.1% -$28.5K 22.12% 1
2022
Q2 		$21.7M Sell
66,844
-35
-0.1% -$10.5K 19.13% 2
2022
Q1 		$19.2M Sell
66,879
-180
-0.3% -$46.3K 14.39% 2
2021
Q4 		$18.5M Sell
67,059
-600
-0.9% -$152K 13.44% 2
2021
Q3 		$15.6M Sell
67,659
-50
-0.1% -$12.3K 12.66% 2
2021
Q2 		$15.5M Sell
67,709
-270
-0.4% -$54.2K 12.6% 2
2021
Q1 		$12.7M Sell
67,979
-1,054
-2% -$206K 14.45% 1
2020
Q4 		$11.7M Buy
69,033
+340
+0.5% +$50.8K 13.57% 1
2020
Q3 		$10.2M Buy
68,693
+175
+0.3% +$27.1K 12.74% 1
2020
Q2 		$10.5M Buy
68,518
+770
+1% +$118K 13.15% 1
2020
Q1 		$9.4M Buy
67,748
+75
+0.1% +$10.3K 11.72% 2
2019
Q4 		$8.89M Buy
+67,673
New +$7.84M 9.45% 2

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Indie Asset Partners's LLY Position: Q2 2026 in Review

Indie Asset Partners increased its Eli Lilly (LLY) stake by 4.3% in Q2 2026, buying an estimated $412K and bringing the position to 9,677 shares worth $11.6M. The position accounts for 11.12% of the portfolio, ranked #1.

Indie Asset Partners first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. The position peaked at $55M in Q2 2024. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Indie Asset Partners held 9,677 shares of Eli Lilly worth $11.6M as of Q2 2026.
  • Indie Asset Partners bought 403 Eli Lilly shares in Q2 2026, an estimated $412K.
  • Eli Lilly made up 11.12% of Indie Asset Partners's portfolio in Q2 2026, its #1 holding.
  • Indie Asset Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • Indie Asset Partners's Eli Lilly position peaked at $55M in Q2 2024.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Indie Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.